Targeting cancer cells through antibiotics-induced mitochondrial dysfunction requires autophagy inhibition

被引:36
作者
Esner, Milan [1 ]
Graifer, Dmitry [2 ]
Lleonart, Matilde E. [3 ]
Lyakhovich, Alex [3 ,4 ,5 ,6 ]
机构
[1] Masaryk Univ, Dept Histol & Embryol, Fac Med, Brno, Czech Republic
[2] Novosibirsk State Univ, Pirogova 2, Novosibirsk 630090, Russia
[3] Vall dHebron Inst Recerca VHIR, Translat Res Canc Stem Cells, Barcelona, Spain
[4] Novosibirsk Inst Mol Biol & Biophys, Novosibirsk, Russia
[5] Int Clin Res Ctr, ICRC FNUSA, Brno, Czech Republic
[6] St Annes Univ Hosp Brno, Brno, Czech Republic
关键词
Antibiotics; Mitochondrial dysfunction; Mitochondria; Cancer; Autophagy; Mitophagy; FANCONI-ANEMIA CELLS; RESISTANCE; MANNER;
D O I
10.1016/j.canlet.2016.09.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A significant part of current research studies utilizes various cellular models which imply specific antibiotics-containing media as well as antibiotics used for clonal selection or promoter de/activation. With the great success of developing such tools, mitochondria, once originated from bacteria, can be effectively targeted by antibiotics. For that reason, some studies propose antibiotics-targeting of mitochondria as part of anticancer therapy. Here, we have focused on the effects of various classes of antibiotics on mitochondria in cancer and non-cancer cells and demonlow mitochondrial membrane potential, reduced ATP production, altered morphology and lowered respiration rate which altogether suggested mitochondrial dysfunction (MDF). This was in parallel with increased level of reactive oxygen species (ROS) and decreased activity of mitochondria( respiration complexes. However, both survival and repopulation capacity of cancer cells was not significantly affected by the antibiotics, perhaps due to a glycolytic shift or activated autophagy. In turn, simultaneous inhibition of autophagy and treatment with antibiotics largely reduced tumorigenic properties of cancer cells suggesting potential strategy for anticancer therapy. (C) 2016 Published by Elsevier Ireland Ltd.
引用
收藏
页码:60 / 69
页数:10
相关论文
共 19 条
[1]   Endosymbiosis and Eukaryotic Cell Evolution [J].
Archibald, John M. .
CURRENT BIOLOGY, 2015, 25 (19) :R911-R921
[2]   Antibiotic use and its consequences for the normal microbiome [J].
Blaser, Martin J. .
SCIENCE, 2016, 352 (6285) :544-545
[3]   Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void? [J].
Brown, David .
NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (12) :821-832
[4]   2016: A 'Mitochondria' Odyssey [J].
Cherry, Catherine ;
Thompson, Brian ;
Saptarshi, Neil ;
Wu, Jianyu ;
Hoh, Josephine .
TRENDS IN MOLECULAR MEDICINE, 2016, 22 (05) :391-403
[5]   Anti-protozoal and anti-bacterial antibiotics that inhibit protein synthesis kill cancer subtypes enriched for stem cell-like properties [J].
Cuyas, Elisabet ;
Martin-Castillo, Begona ;
Corominas-Faja, Bruna ;
Massaguer, Anna ;
Bosch-Barrera, Joaquim ;
Menendez, Javier A. .
CELL CYCLE, 2015, 14 (22) :3527-3532
[6]   Functions and dysfunctions of mitochondrial dynamics [J].
Detmer, Scott A. ;
Chan, David C. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (11) :870-879
[7]   Mitophagy is triggered by mild oxidative stress in a mitochondrial fission dependent manner [J].
Frank, Magdalena ;
Duvezin-Caubet, Stephane ;
Koob, Sebastian ;
Occhipinti, Angelo ;
Jagasia, Ravi ;
Petcherski, Anton ;
Ruonala, Mika O. ;
Priault, Muriel ;
Salin, Benedicte ;
Reichert, Andreas S. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2012, 1823 (12) :2297-2310
[8]   BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells [J].
Goulielmaki, Maria ;
Koustas, Evangelos ;
Moysidou, Eirini ;
Vlassi, Margarita ;
Sasazuki, Takehiko ;
Shirasawa, Senji ;
Zografos, George ;
Oikonomou, Eftychia ;
Pintzas, Alexander .
ONCOTARGET, 2016, 7 (08) :9188-9221
[9]   Insufficient Autophagy Contributes to Mitochondrial Dysfunction, Organ Failure, and Adverse Outcome in an Animal Model of Critical Illness [J].
Gunst, Jan ;
Derese, Inge ;
Aertgeerts, Annelies ;
Ververs, Eric-Jan ;
Wauters, Andy ;
Van den Berghe, Greet ;
Vanhorebeek, Ilse .
CRITICAL CARE MEDICINE, 2013, 41 (01) :182-194
[10]   Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner [J].
Hu, Huanrong ;
Dong, Zhen ;
Tan, Peng ;
Zhang, Yanli ;
Liu, Lichao ;
Yang, Liqun ;
Liu, Yaling ;
Cui, Hongjuan .
ONCOTARGET, 2016, 7 (03) :3171-3185